Fig. 2.
Fig. 2. Inhibition of VEGF binding to Flt-1 by mAb KM1732 and flow cytometric analysis of HUVEC with mAbs. / (A) Inhibition of specific 125I-VEGF binding to Flt-1 7N or KDR 7N-Fc by anti–Flt-1 mAb, KM1732. Experimental details are given in “Materials and methods.” The profiles of KM1732 (○) and control KM231 (▴) are shown. Arrowhead (dashed line), inhibitor 0 μg/mL. (B) Flow cytometric analysis of HUVEC, binding with antihuman Flt-1 mAbs, KM1730 and KM1732, or antihuman KDR mAb, KM1992. HUVECs were stained with KM1730, KM1732, KM1992, or control mouse IgG1 mAb and analyzed by flow cytometry.

Inhibition of VEGF binding to Flt-1 by mAb KM1732 and flow cytometric analysis of HUVEC with mAbs.

(A) Inhibition of specific 125I-VEGF binding to Flt-1 7N or KDR 7N-Fc by anti–Flt-1 mAb, KM1732. Experimental details are given in “Materials and methods.” The profiles of KM1732 (○) and control KM231 (▴) are shown. Arrowhead (dashed line), inhibitor 0 μg/mL. (B) Flow cytometric analysis of HUVEC, binding with antihuman Flt-1 mAbs, KM1730 and KM1732, or antihuman KDR mAb, KM1992. HUVECs were stained with KM1730, KM1732, KM1992, or control mouse IgG1 mAb and analyzed by flow cytometry.

Close Modal

or Create an Account

Close Modal
Close Modal